BeOne Medicines (ONC) Other Non Operating Income (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Other Non Operating Income of $14.5 million for Q1 2026, up 268.0% year-over-year from $4.0 million in Q1 2025, and up 140.73% quarter-over-quarter from -$35.7 million in Q4 2025.
BeOne Medicines (ONC) Other Non Operating Income (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Other Non Operating Income for 12 consecutive years, with $14.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 268.0% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at -$32.0 million (down 205.9% YoY), while the FY2025 annual figure was -$42.6 million, down 236.71% from the prior year.
- Other Non Operating Income climbed to $14.5 million in Q1 2026 per ONC's latest filing, from -$35.7 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $336.7 million in Q3 2023 and bottomed at -$129.6 million in Q2 2022.
- Historically, Other Non Operating Income has averaged $2.6 million across 5 years, with a median of $4.0 million in 2025.
- On a YoY basis, Other Non Operating Income climbed as much as 390.25% in 2022 and fell as far as 14850.06% in 2022.
- BeOne Medicines' Other Non Operating Income stood at $19.4 million in 2022, then fell by 13.83% to $16.7 million in 2023, then tumbled by 182.0% to -$13.7 million in 2024, then plunged by 159.87% to -$35.7 million in 2025, then jumped by 140.73% to $14.5 million in 2026.
- Business Quant data shows ONC's Other Non Operating Income at $14.5 million in Q1 2026, -$35.7 million in Q4 2025, and -$19.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -749,000.00 |
| Mar 31, 2026 | 14.54 Mn |
| Dec 31, 2025 | -35.69 Mn |
| Sep 30, 2025 | -18.98 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Dec 31, 2024 | -13.73 Mn |
| Sep 30, 2024 | 11.32 Mn |
| Jun 30, 2024 | -11.98 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 16.75 Mn |
| Sep 30, 2023 | 336.66 Mn |
| Jun 30, 2023 | -63.82 Mn |
| Mar 31, 2023 | 18.30 Mn |
| Dec 31, 2022 | 19.44 Mn |
| Sep 30, 2022 | -125.64 Mn |
| Jun 30, 2022 | -129.62 Mn |
| Mar 31, 2022 | 11.97 Mn |
| Dec 31, 2021 | -800.16 Mn |
| Sep 30, 2021 | 31.48 Mn |